Rosiridin(CAS: 100462-37-1)

Rosiridin (CAS: 100462-37-1) should comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the EU, and FDA/EPA requirements for chemical substances. It is important to consult the Material Safety Data Sheet (MSDS) and adhere to local and international regulations regarding its handling, storage, and disposal.

Several alternatives to Rosiridin, including analogs and isomers, can be used in synthesis. Common substitutes include 1-Naphthylacetic acid and 2-Methoxy-5-hydroxymethylpyridine. These compounds offer similar functionalities and can be selected based on the specific requirements and availability.

The market for Rosiridin (CAS: 100462-37-1) is growing due to its potential in cancer research and therapy. Research trends focus on its anticancer properties and the development of new derivatives. Prices are stable, and demand is increasing as more studies validate its therapeutic potential.

Waste containing Rosiridin (CAS: 100462-37-1) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration may be required depending on local regulations. Ensure to follow all environmental protection precautions and consult the MSDS for specific disposal instructions to prevent environmental contamination and safety hazards.